VANDYCK, KOEN,VERSCHUEREN, WIM, GASTON,RABOISSON, PIERRE, JEAN-MARIE, BERNARD
申请号：
CL2015000483
公开号：
CL2015000483A1
申请日:
2015.02.27
申请国别(地区):
CL
年份:
2015
代理人:
摘要：
Inhibitors of HBV replication of Formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein A-E, R1, R2, R3 and R5, have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.COMPUESTOS (HETERO)BICICLOS FUSIONADOS DERIVADOS DE 1-(FENILAMINO)-INDENO-6-SULFONAMIDA； COMPOSICION FARMACEUTICA QUE LOS COMPRENDE； Y PRODUCTO FARMACÉUTICO QUE LOS CONTIENE, ÚTILES EN EL TRATAMIENTO DE LA HEPATITIS B (VBH).
